Infliximab in severe ulcerative colitis: Short-term results of different infusion regimens and long-term follow-up

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2007, Pages 747-756

  Kohn, A ^a   Daperno, M ^b   Armuzzi, A ^c   Cappello, M ^d   Biancone, L ^e   Orlando, A ^f   Viscido, A ^g   Annese, V ^h   Riegler, G ⁱ   Meucci, G ^j   Marrollo, M ^a   Sostegni, R ^b   Gasbarrini, A ^c   Peralta, S ^d   Prantera, C ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

^j VALDUCE HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHYLPREDNISOLONE;

ADULT; ARTICLE; BACTERIAL INFECTION; CAUSE OF DEATH; COLON RESECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REFRACTORY PERIOD; SHORT COURSE THERAPY; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; MALE; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547844144     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03415.x     Document Type: Article

References (42)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part 1: short-term prognosis. Gut 1963 4:300 8.
2. Stenson WF. Inflammatory bowel disease. In:Yamada T ed. Textbook of Gastroenterology: A Community Study, 2nd ed. Philadelphia:JB Lippincott Company, 1995:1748 806
3. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974 1:1067 70.
4. Järnerot G, Rolny P, Sandberg-Gertzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985 89:1005 13.
5. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996 38:905 10.
6. Carbonnel F, Gargouri D, Lemann M, et al. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000 14:273 9.
7. Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004 19:1079 87.
8. Cohen RD, Brodsky AL, Hannauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999 5:1 10.
9. Lichtiger S, Present DH, Kornbluth A, et al. Cyclopsporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 330:1841 51.
10. Carbonnel F, Boruchowitz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 1996 41:2471 6.
11. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004 10:73 8.
12. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 353:2462 76.
13. Järnerot G, Hertevig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized placebo-controlled study. Gastroenteroloy 2005 128:1805 11.
14. Chey WY, Hussain A, Ryan C, et al. Infliximab for refractory ulcerative colitis. Am J Gastroenterol 2001 96:2373 81.
15. Kohn A, Prantera C, Pera A, et al. Anti-tumor necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Dig Liver Dis 2003 34:626 30.
16. Kaser A, Mairinger T, Vogel W, et al. Infliximab in severe steroid-refractory ulcerative colitis (a pilot study). Wien Klin Wochenschr 2001 113:930 3.
17. Eidelwein AP, Cuffari C, Abadom V, et al. Infliximab efficacy in pediatric ulcerative colitis. Inflammatory Bowel Dis 2005 11:213 8.
18. Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001 7:83 8.
19. Kohn A, Prantera C, Pera A, et al. Infliximab in the treatment of severe ulcerative colitis: a follow-up study. Eur Rev Med Pharmacol Sci 2004 8:235 7.
20. Prantera C, Lorenzetti R, Cerro P, et al. The plain abdominal film accurately estimates extent of active ulcerative colitis. J Clin Gastroenterol 1991 13:231 4.
21. Carbonnel F, Lavergne A, Lemann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994 39:1550 7.
22. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955 2:1041 8.
23. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Gut 1986 27:1210 2.
24. Lichtiger S, Present D. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990 336:16 9.
25. Bland M. An Introduction to Medical Statistics,. Oxford, UK:Oxford University Press, 2000.
26. Marchal L, D'Haens G, Van Assche G, et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004 19:749 54.
27. Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007 204:956 62.
28. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994 154:2417 22.
29. Stout JE, Yu VL. Legionellosis. N Engl J Med 1997 337:682 7.
30. Li Gobbi F, Benucci M, Del Rosso A. Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab). J Clin Rheumatol 2005 11:119 20.
31. Wondergem MJ, Voskuyl AE, van Agtmael MA. A case of legionellosis during treatment with a TNFalpha antagonist. Scand J Infect Dis 2004 36:310 1.
32. Albert C, Vandebos F, Brocq O, et al. Legionellosis in patient treated with infliximab. Rev Med Interne 2004 25:167 8.
33. Eisendle K, Fritsch P. Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy. Br J Dermatol 2005 152:585 6.
34. McHugh SL, Newton CA, Yamamoto Y, et al. Tumour necrosis factor induces resistance of macrophages to Legionella pneumophila infection. Proc Soc Exp Biol Med 2000 124:191 6.
35. Skerrett SJ, Bagby GJ, Schmidt RA, et al. Antibody-mediated depletion of tumour necrosis factor-a impairs pulmonary host defences to Legionella pneumophila. J Infect Dis 1997 176:1019 28.
36. Shibolet O, Requshevskaya E, Brezis M, et al. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev 2005 1:CD004277.
37. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterology 1999 94:1587 92.
38. Alves A, Panis Y, Bounhik Y, et al. Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy. J Am Coll Surg 2003 197:379 85.
39. Seelig MH, Uhlig H, Braun J, et al. Surgical therapy of severe colitis. Chirug 1996 67:150 54s.
40. Longo WE, Virgo KS, Bahadursingh AN, et al. Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg 2003 186:514 8.
41. Jacobovits SL, Travis SP. Management of acute severe colitis. Br Med Bull 2006 76:131 44.
42. Hahnloser D, Pemberton JH, Wolff BG, et al. The effect of aging on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis. Ann Surg 2004 240:615 21.